创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Characteristics and Application Prospects of 3D Organoid Platforms

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-06-20 14:44
  • Views:

(Summary description)With the rapid development of biotechnology, scientists are becoming increasingly sophisticated in their understanding and simulation of the complex structures inside living organisms. With its advanced 3D organoid platform, InnoModels Biotechnology provides us with an unprecedented way to study the various organ structures of living organisms. The characteristics of this platform are not only in its ability to highly simulate the real conditions of living organisms, but also in its wide range of applications and powerful experimental capabilities.

InnoModels Biotechnology: Characteristics and Application Prospects of 3D Organoid Platforms

(Summary description)With the rapid development of biotechnology, scientists are becoming increasingly sophisticated in their understanding and simulation of the complex structures inside living organisms. With its advanced 3D organoid platform, InnoModels Biotechnology provides us with an unprecedented way to study the various organ structures of living organisms. The characteristics of this platform are not only in its ability to highly simulate the real conditions of living organisms, but also in its wide range of applications and powerful experimental capabilities.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-06-20 14:44
  • Views:
Information

With the rapid development of biotechnology, scientists are becoming increasingly sophisticated in their understanding and simulation of the complex structures inside living organisms. With its advanced 3D organoid platform, InnoModels Biotechnology provides us with an unprecedented way to study the various organ structures of living organisms. The characteristics of this platform are not only in its ability to highly simulate the real conditions of living organisms, but also in its wide range of applications and powerful experimental capabilities.
First of all, the 3D organoid platform of InnoModels Biotechnology has the feature of multi-cell type support. This feature enables the platform to simulate a variety of complex organ structures, including but not limited to liver, heart and lungs. By introducing multiple cell types, this platform is able to reconstruct structures that are closer to the internal environment of real organisms, providing scientists with a broader scope of research. Whether it is the study of disease mechanisms or the evaluation of drug effects, this support of multiple cell types makes the experiments more accurate and reliable.
Secondly, 3D organoid platform of InnoModels Biotechnology excels in physiological function restoration. The platform is able to simulate the physiological functions of organoids through well-designed culture conditions and support structures, making them closer to the biological properties of organs in the body. This reduction not only enhances the reliability of experimental results, but also makes the platform an ideal tool for disease modeling research. Scientists can utilize this platform to study the development process of diseases and the therapeutic effects of drugs on diseases, providing strong support for future medical research and treatment.

 


Furthermore, the 3D organoid platform of InnoModels Biotechnology also features high-throughput screening. High-throughput screening is a crucial part of the drug development and evaluation process. This platform can support a large number of experiments at the same time, which greatly improves the experimental efficiency and shortens the time of drug development and evaluation. At the same time, due to the high degree of simulation of this platform, the experimental results are also more informative, helping scientists to more accurately assess the effectiveness and safety of drugs.
In addition, it is worth mentioning that the 3D organoid platform of InnoModels Biotechnology is also highly customizable and scalable. Scientists can customize the culture conditions and cell types according to specific research needs, thus creating organoids with specific physiological properties. Meanwhile, as technology advances, the platform is also expected to support a wider variety of cell types and more complex organoid structures, providing more possibilities for future scientific research.
Overall, the 3D organoid platform of InnoModels Biotechnology shows strong application potential and prospects with its features of multi-cell type support, physiological function reduction and high-throughput screening. It can not only be used for research on disease mechanisms and evaluation of drug effects, but also provide strong support for biomedical engineering, regenerative medicine and other fields. In the future, with the further development and improvement of the technology, we have reason to believe that the 3D organoid platform of InnoModels will play an even more important role in scientific research and medical practice. 

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司